Coming Soon! Breast Macrodissect AI
Reliable tumor content analysis for breast carcinoma specimens.
Coming Soon! Breast Macrodissect AI Read More »
Clinical Products
CRC Macrodissect AI
Reliable tumor content analysis for colorectal carcinoma specimens.
CRC Macrodissect AI Read More »
Lung Macrodissect AI
Reliable tumor content analysis for non-small cell lung cancer specimens.
Lung Macrodissect AI Read More »
HALO Macrodissection Solutions
AI-powered tools that quantify tumor content and guide ROI selection to enhance macrodissection workflows and downstream molecular analysis.
HALO Macrodissection Solutions Read More »
HALO AP Dx
HALO AP Dx is an FDA-cleared case-centric pathology platform that enables primary diagnosis, remote working, and other routine workflows in anatomic pathology.
Breast IHC AI
An automated, AI-based decision-support tool that standardizes scoring of HER2, ER, PR, and Ki67 IHC in breast cancer cases.
Lung PD-L1 AI
An automated, AI-based decision-support tool that standardizes the scoring of PD-L1 IHC in NSCLC cases.
SlideQC BF
An automated, AI-based tool for quality control of whole slide H&E- and IHC-stained images.
Lung PD-L1 AI: Development and Validation of an Automated PD-L1 Tumor Proportion Scoring Algorithm in Non-Small Cell Lung Cancer
30 November 2023 | Learn how to implement Lung PD-L1 AI to assist PD-L1 scoring in non-small cell lung cancer
Sneak Peek: HALO AP® 2.2 and Breast IHC AI
28 September 2023 | Please join us for this 1-hour webinar to learn about the exciting new features of our AI-powered, pathologist-driven digital pathology platform, HALO AP, and our Breast IHC AI suite
Sneak Peek: HALO AP® 2.2 and Breast IHC AI Read More »